Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry ; volume:25 ; number:1 ; day:19 ; month:9 ; year:2023 ; pages:1-13 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (19.9.2023), 1-13, 12.2023
- Creator
-
Jung, Ju-Yang
Lee, Eunyoung
Kim, Ji-Won
Suh, Chang-Hee
Shin, Kichul
Kim, Jinhyun
Kim, Hyoun-Ah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03165-w
- URN
-
urn:nbn:de:101:1-2024020710450838633478
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jung, Ju-Yang
- Lee, Eunyoung
- Kim, Ji-Won
- Suh, Chang-Hee
- Shin, Kichul
- Kim, Jinhyun
- Kim, Hyoun-Ah
- SpringerLink (Online service)
Other Objects (12)
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report
Endotyping Difficult-to-Treat Chronic Rhinosinusitis with Nasal Polyps by Structured Histopathology
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report
Endotyping Difficult-to-Treat Chronic Rhinosinusitis with Nasal Polyps by Structured Histopathology
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Intestinal tuberculosis masquerading as difficult to treat Crohn disease: a case report